Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. (Q27852177)
Jump to navigation
Jump to search
scientific article
- Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. |
scientific article |
|
Statements
2 references
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma (English)
Sandra P D'Angelo
Mrinal M Gounder
Mark A Dickson
William D Tap
Mary Louise Keohan
Cristina R Antonescu
Li-Xuan Qin
Dustin D Rathbone
Mercedes M Condy
Yelena Ustoyev
Gary K Schwartz
8 April 2013
1 reference
1 reference
Identifiers
2 references
2 references
2 references